↓ Skip to main content

A phase I/II clinical trial of ex-vivo expanded human bone marrow derived allogeneic mesenchymal stromal cells in adult patients with perianal fistulizing Crohn’s Disease

Overview of attention for article published in Stem Cell Research & Therapy, May 2024
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (82nd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

twitter
11 X users
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A phase I/II clinical trial of ex-vivo expanded human bone marrow derived allogeneic mesenchymal stromal cells in adult patients with perianal fistulizing Crohn’s Disease
Published in
Stem Cell Research & Therapy, May 2024
DOI 10.1186/s13287-024-03746-9
Pubmed ID
Authors

Shekhar Swaroop, Sudheer Kumar Vuyyuru, Bhaskar Kante, Peeyush Kumar, Sandeep Kumar Mundhra, Umang Arora, Ankur Goyal, Devasenathipathy Kandasamy, Raju Sharma, Kavirajan Kabilan, Saurabh Kedia, Nihar Ranjan Dash, Vineet Ahuja

X Demographics

X Demographics

The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 May 2024.
All research outputs
#4,513,817
of 26,009,886 outputs
Outputs from Stem Cell Research & Therapy
#471
of 2,825 outputs
Outputs of similar age
#36,677
of 203,230 outputs
Outputs of similar age from Stem Cell Research & Therapy
#14
of 32 outputs
Altmetric has tracked 26,009,886 research outputs across all sources so far. Compared to these this one has done well and is in the 82nd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,825 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 203,230 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 32 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.